Zion Market Research has published a new report titled “Veterinary Artificial Insemination Market by Animal Type (Ruminants, Equine, Canine and Feline and Other), Technique (Intrauterine Tuboperitoneal Insemination, Intracervical Insemination, Intrauterine Insemination, and Intratubal Insemination) and End user (Veterinary Hospitals, Veterinary Clinics and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”. According to the report, global demand for Veterinary Artificial Insemination Market was valued at approximately USD 1708.36 Million in 2018, and is expected to generate revenue of around USD 2386.24 Million by end of 2025, growing at a CAGR of around 4.92% between 2018 and 2025.
Artificial insemination is a method of manually inserting semen without natural mating into the reproductive tract of women. Artificial insemination is one of the great biotechnology techniques used to improve the reproduction and genetics of farm animals. Artificial insemination is a procedure to manually inject semen without natural mating into the reproductive tract of women. Artificial Insemination is one of the great biotechnology techniques used to improve the reproduction and genetics of farm animals. Moreover, increasing understanding of sexually transmitted diseases in animals is being used in livestock to prevent STD’s AI, increasing technological advances, increasing reliability in protecting endangered species and increasing the protection of their habitats is driving the global Veterinary Artificial Insemination market.
Request Free Sample is Available @ https://www.zionmarketresearch.com/sample/veterinary-artificial-insemination-market
It is anticipated that through adoption of semen sexing technology through beef and dairy herds would fuel market growth due to the related advantage of centered breeding animal selection to produce a stronger next generation. Genus ABS, one of the market’s leading players, rebounded sharply in 2018 after the successful launch of Sexcel in 2017. After the launch, the company’s sales rose to almost 25 percent in 2018, representing high demand and adoption in developed countries. With the technique becoming increasingly popular, many producers collect semen from top herd sires and make it available to other producers. Moreover, as agricultural conditions and farmers ‘ needs change, most animal breeds are no longer suitable for most farms. However, artificial insemination can be used to generate progenies with the desired traits.
The market for Veterinary Artificial Insemination is segmented based on animal type, technique, end user, and region. Based on Animal Type, the market is segmented into Ruminants, Equine, Canine and Feline and Other. Based on animal type, the ruminant segment held the largest share in 2018 on the market for veterinary artificial insemination. This share can be attributed to different factors, such as the large consumer base of cattle meat & milk products, as well as the growing acceptance of advanced genetic research to improve livestock productivity. Therefore, environmental conditions and the possibility of extinction are key issues faced by animal breeding. As agricultural conditions and farmers ‘ needs change, many of the breeds are no longer suitable for most farms. The best way to use AI as a reproductive tool is to allow even the extinct breeds to start breeding in situ.
Based on the Technique segment, the market is bifurcated Intrauterine Tuboperitoneal Insemination, Intracervical Insemination, Intrauterine Insemination, and Intratubal Insemination. Based on the End user segment, the market is bifurcated into Veterinary Hospitals, Veterinary Clinics and Others. The segment of veterinary hospitals held the highest end-use market share in 2018. This can be attributed to the growing adoption of genomic tests by farm owners to avoid financial losses and loss of productivity of animals. More than 90 percent of U.S. veterinary hospitals offered insemination services in 2018, according to the American Veterinary Medical Association.
Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. A big share in 2018 was the largest cattle population in Asia Pacific. According to the Brazilian Association of Artificial Insemination (BAAI), the number of commercialized semen doses increased from over 7 million in 2003 to over 14 million in 2017. India and China are the countries with a population of over 30% of the world’s cattle. Europe is seeing an increase in the adoption of AI technology for cattle producing milk as a result of increased awareness and environmental concerns. In 2015, when WHO reported a higher risk of developing cancer in a meat diet, a majority of the population moved to vegan diet. This increased the need for milk and its products to meet protein & calcium requirements, creating new avenues for growth in the regional market.
Some of the players included in Veterinary Artificial Insemination market are Jorgensen Labs, Merck Animal Health, PBS Animal Health, Revival Animal Health, Santa Cruz Biotechnology, Inc. and Swine Genetics amongst others.
The report segments the Veterinary Artificial Insemination market as follows:
Global Veterinary Artificial Insemination Market: Animal Type Segment Analysis
Global Veterinary Artificial Insemination Market: Technique Segment Analysis
Global Veterinary Artificial Insemination Market: End user Segment Analysis
Global Veterinary Artificial Insemination Market: Regional Segment Analysis
To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/veterinary-artificial-insemination-market